astrazeneca news - Search News

AstraZeneca, China

AstraZeneca talks up US growth as China problems fester

AstraZeneca Plc is increasingly looking to the US for growth as its once fast-expanding China business faces challenges amid a probe that has battered the drugmaker’s share price.

The Financial Times · 2d

AstraZeneca chief says group takes China probe ‘very seriously’

AstraZeneca chief executive Pascal Soriot said the company took the detention of its China president “very seriously”, as the drugmaker raised its guidance for a second straight quarter on the back of strong sales of cancer medicines.

Reuters on MSN · 2d

AstraZeneca CEO says detained China chief has a lawyer but 'we have no information'

AstraZeneca's CEO said on Tuesday that the company's China president Leon Wang, who last month was detained by Chinese authorities, has a lawyer he is in touch with, but "we have no information as a company".

Barron's · 2d

Pharma Giant AstraZeneca Takes China Probes 'Very Seriously'

British pharmaceutical giant AstraZeneca on Tuesday said it takes "very seriously" China's investigations into potential illegal data collection and drug imports by the group that caused the detention of its China boss.

8hon MSN

Is AstraZeneca a Buy as It Eyes the Weight Loss Market?

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

Outsourcing-pharma6h

AstraZeneca doubles down on US manufacturing with $3.5 billion investment

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...

2don MSN

AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on US investments

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

Hosted on MSN2d

AstraZeneca Expands U.S. Investment Plan

AstraZeneca said it plans to pump $2 billion in new investment into the U.S., one of the first major foreign companies to ...

STAT2d

Pharmalittle: We’re reading about 23andMe retrenching, AstraZeneca reworking cancer drug plans, and more

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

AstraZeneca says detained China head has lawyer, but company still in dark

AstraZeneca's China president Leon Wang, who was detained last month by Chinese authorities, is in touch with a lawyer but ...

Business Insider20h

AstraZeneca: Overcoming Short-term Challenges with Robust Long-term Potential

Bernstein analyst Justin Smith maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of p18,000.00. Justin Smith has given his Buy rating due to a combination ...

STAT2d

AstraZeneca, Daiichi Sankyo change strategy on closely watched cancer drug

LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of ...

2don MSN

AstraZeneca: 450 million pound investment in UK on hold amid talks with govt

London-listed drugmaker AstraZeneca said its plan to invest 450 million pounds ($576.7 million) in Britain for vaccine ...

Bisnow1d

AstraZeneca To Invest $3.5B To Grow U.S. Footprint

Cambridge, England-based biopharmaceutical giant AstraZeneca is pouring billions of dollars into properties in the United ...

AstraZeneca Raises Outlook, Plans U.S. Investment

AstraZeneca raised its full-year guidance after third-quarter results topped analysts’ expectations, boosted by its cancer ...

Daily11h

AstraZeneca, Daiichi Sankyo submits Datopotamab deruxtecan new BLA for accelerated approval in US for lung cancer

AstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated approval in the US ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

AstraZeneca, China

Related topics